Leaflet LEVAMISOL ARENA 150mg tablets


Indicated for: parasitic infections

Route of administration: oral

Substance: levamisole (anthelmintic)

ATC: P02CE01 (Antiparasitic products, insecticides and repellents | Antinematodal agents | Imidazothiazole derivatives)

Levamisole is a medication primarily used as an anthelmintic to treat parasitic infections, particularly those caused by roundworms. It is effective in eliminating intestinal parasites by paralyzing them, thus facilitating their removal from the body.

In addition to its use as an anthelmintic, levamisole has also been used as an immunomodulator in certain autoimmune and oncological conditions, although this use is less common today. In the past, it was employed as an adjuvant in the treatment of certain cancers, such as colon cancer, but its use has declined due to side effects and the availability of more effective treatments.

Side effects of levamisole include nausea, vomiting, diarrhea, and, in rare cases, severe allergic reactions or bone marrow suppression. It is important that the medication is taken as prescribed by a doctor, and its use should be carefully monitored.

General data about LEVAMISOL ARENA 150mg

  • Substance: levamisole
  • Date of last drug list: 01-05-2026
  • Commercial code: W55331001
  • Concentration: 150mg
  • Pharmaceutical form: tablets
  • Quantity: 1
  • Product type: generic
  • Price: 12.30 RON
  • Prescription restrictions: P-RF - Medicines prescription that is retained in the pharmacy (not renewable).

Marketing authorisation

  • Manufacturer: ARENA GROUP S.A. - ROMANIA
  • Holder: ARENA GROUP S.A. - ROMANIA
  • Number: 12754/2019/01
  • Shelf life: 3 years

Concentrations available for levamisole

  • 150mg
  • 50mg

Compensation lists for LEVAMISOL ARENA 150mg Arena

A - Sublist A with 90% discount from the reference price

Price

Copayment

Patient

12.30 RON

11.07 RON

1.23 RON